02 Mar 2015 - 05 Mar 2015
Witness the latest product trends, consumer insights and innovative offerings in OTC.
This conference aims to answer the following questions:
Where is the biggest growth opportunity in Asia?
How have consumer characteristics evolved in key markets?
What are the latest regulatory changes and their impact OTC approvals, marketing and distribution?
What are the latest product offerings and innovation and how can you introduce “newness” in existing products?
How can OTC players position themselves and reinforce brand messages?
How have pharma companies transited their products from RX to OTC successfully?
At IBC’s OTC Pharma Asia Conference, top speakers will come together to uncover strategies on how to tackle the above issues with practical case studies . The expert panel includes representatives such as:
Michael Hofer, Regional Market Expansion Services Manager, Business Unit Healthcare, DKSH
Dr Deepak Kotak, Executive Vice President, BioElectronics
Rehan Khan, Managing Director, Abbott
Ding Ming, Global Wellness Category Medical Director, GlaxoSmithKline Consumer Healthcare
Dr Noppadon (Nhum) Adjimatera, South East Asia (SEA) Regional Regulatory and Medical Affairs Director, Reckitt Benckiser
Vineet Singhal, Operating Unit Head – India and South East Asia (OTC Division), Novartis Consumer Health
Reg Wuisan, Executive Director, PT. Asia Pacific Consultants, Past Vice Chair of ASEAN Alliance of Health Supplements Associations
Brijesh Kapil, General Manager, Merck Consumer Health
Martina Gripp, Head of Marketing CHC Region South East Asia and South Korea, Boehringer Ingelheim
Click here for the complete list of speakers and full agenda.
For more information, please click here to visit the event website.
Read More from OBG
